Global Neutropenia Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

好中球減少症治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

◆タイトル:Global Neutropenia Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
◆商品コード:GIR8104458
◆調査・発行会社:Global Info Research
◆発行日:2018年10月2日
◆ページ数:117
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール
◆調査対象地域:世界
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥368,880見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥553,320見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥737,760見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Info Researchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは、好中球減少症治療の世界市場について調べ、まとめました。種類別セグメントは、顆粒球コロニー刺激因子(G-CSF)、抗生物質、抗真菌薬等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。好中球減少症治療の世界市場概観、メーカー動向、メーカー別好中球減少症治療シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・好中球減少症治療の市場概観
・好中球減少症治療のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・好中球減少症治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・好中球減少症治療の世界市場規模
・好中球減少症治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・好中球減少症治療のアメリカ市場規模推移
・好中球減少症治療のカナダ市場規模推移
・好中球減少症治療のメキシコ市場規模推移
・好中球減少症治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・好中球減少症治療のドイツ市場規模推移
・好中球減少症治療のイギリス市場規模推移
・好中球減少症治療のロシア市場規模推移
・好中球減少症治療のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・好中球減少症治療の日本市場規模推移
・好中球減少症治療の中国市場規模推移
・好中球減少症治療の韓国市場規模推移
・好中球減少症治療のインド市場規模推移
・好中球減少症治療の東南アジア市場規模推移
・好中球減少症治療の南米市場分析(ブラジル、アルゼンチン等)
・好中球減少症治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・好中球減少症治療の種類別分析/市場規模推移(顆粒球コロニー刺激因子(G-CSF)、抗生物質、抗真菌薬)
・好中球減少症治療の用途別分析/市場規模推移(病院薬局、小売薬局、オンライン薬局)
・好中球減少症治療の市場予測(地域別予測、種類別予測、用途別予測)
・好中球減少症治療の販売チャネル・代理店・貿易業者・ディーラー分析

Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible to infections and may even prove fatal. Therefore, the condition requires immediate prophylaxis.

Scope of the Report:

This report studies the Neutropenia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neutropenia Treatment market by product type and applications/end industries.

Novel therapies combined with growing cases of chemotherapy-induced neutropenia is one of the primary drivers for market growth. Moreover, the novel drug delivery technique also improves patient convenience leading to better patient adherence thus driving the market growth. Furthermore, since cancer is the known cause for developing neutropenia, the increasing cases of chemotherapy for the treatment of cancer will be a growth driver for the neutropenia treatment market.

The global Neutropenia Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neutropenia Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Amgen

Novartis

Teva Pharmaceutical

Hospira

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Granulocyte -colony- stimulating factor (G-CSF)

Antibiotics

Antifungal drugs

Market Segment by Applications, can be divided into

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

【レポートの目次】

Table of Contents

1 Neutropenia Treatment Market Overview

1.1 Product Overview and Scope of Neutropenia Treatment

1.2 Classification of Neutropenia Treatment by Types

1.2.1 Global Neutropenia Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Neutropenia Treatment Revenue Market Share by Types in 2017

1.2.3 Granulocyte -colony- stimulating factor (G-CSF)

1.2.4 Antibiotics

1.2.5 Antifungal drugs

1.3 Global Neutropenia Treatment Market by Application

1.3.1 Global Neutropenia Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Neutropenia Treatment Market by Regions

1.4.1 Global Neutropenia Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Neutropenia Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neutropenia Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Neutropenia Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Neutropenia Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Neutropenia Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Teva Pharmaceutical

2.3.1 Business Overview

2.3.2 Neutropenia Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceutical Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Hospira

2.4.1 Business Overview

2.4.2 Neutropenia Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Hospira Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Neutropenia Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Neutropenia Treatment Market Competition, by Players

3.1 Global Neutropenia Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Neutropenia Treatment Players Market Share

3.2.2 Top 10 Neutropenia Treatment Players Market Share

3.3 Market Competition Trend

4 Global Neutropenia Treatment Market Size by Regions

4.1 Global Neutropenia Treatment Revenue and Market Share by Regions

4.2 North America Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Neutropenia Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Neutropenia Treatment Revenue and Growth Rate (2013-2018)

5 North America Neutropenia Treatment Revenue by Countries

5.1 North America Neutropenia Treatment Revenue by Countries (2013-2018)

5.2 USA Neutropenia Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Neutropenia Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6 Europe Neutropenia Treatment Revenue by Countries

6.1 Europe Neutropenia Treatment Revenue by Countries (2013-2018)

6.2 Germany Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.4 France Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Neutropenia Treatment Revenue by Countries

7.1 Asia-Pacific Neutropenia Treatment Revenue by Countries (2013-2018)

7.2 China Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.5 India Neutropenia Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

8 South America Neutropenia Treatment Revenue by Countries

8.1 South America Neutropenia Treatment Revenue by Countries (2013-2018)

8.2 Brazil Neutropenia Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Neutropenia Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Neutropenia Treatment by Countries

9.1 Middle East and Africa Neutropenia Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Neutropenia Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Neutropenia Treatment Revenue and Growth Rate (2013-2018)

10 Global Neutropenia Treatment Market Segment by Type

10.1 Global Neutropenia Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Neutropenia Treatment Market Forecast by Type (2018-2023)

10.3 Granulocyte -colony- stimulating factor (G-CSF) Revenue Growth Rate (2013-2023)

10.4 Antibiotics Revenue Growth Rate (2013-2023)

10.5 Antifungal drugs Revenue Growth Rate (2013-2023)

11 Global Neutropenia Treatment Market Segment by Application

11.1 Global Neutropenia Treatment Revenue Market Share by Application (2013-2018)

11.2 Neutropenia Treatment Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacy Revenue Growth (2013-2018)

11.4 Retail Pharmacy Revenue Growth (2013-2018)

11.5 Online Pharmacy Revenue Growth (2013-2018)

12 Global Neutropenia Treatment Market Size Forecast (2018-2023)

12.1 Global Neutropenia Treatment Market Size Forecast (2018-2023)

12.2 Global Neutropenia Treatment Market Forecast by Regions (2018-2023)

12.3 North America Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.6 South America Neutropenia Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Neutropenia Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Neutropenia Treatment Picture

Table Product Specifications of Neutropenia Treatment

Table Global Neutropenia Treatment and Revenue (Million USD) Market Split by Product Type

Figure Global Neutropenia Treatment Revenue Market Share by Types in 2017

Figure Granulocyte -colony- stimulating factor (G-CSF) Picture

Figure Antibiotics Picture

Figure Antifungal drugs Picture

Table Global Neutropenia Treatment Revenue (Million USD) by Application (2013-2023)

Figure Neutropenia Treatment Revenue Market Share by Applications in 2017

Figure Hospital Pharmacy Picture

Figure Retail Pharmacy Picture

Figure Online Pharmacy Picture

Table Global Market Neutropenia Treatment Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Neutropenia Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Neutropenia Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Neutropenia Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Neutropenia Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Neutropenia Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Neutropenia Treatment Revenue (Million USD) and Growth Rate (2013-2023)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Neutropenia Treatment Type and Applications

Table Amgen Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Neutropenia Treatment Type and Applications

Table Novartis Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Neutropenia Treatment Type and Applications

Table Teva Pharmaceutical Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Hospira Basic Information, Manufacturing Base and Competitors

Table Hospira Neutropenia Treatment Type and Applications

Table Hospira Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Neutropenia Treatment Type and Applications

Table Pfizer Neutropenia Treatment Revenue, Gross Margin and Market Share (2016-2017)

Table Global Neutropenia Treatment Revenue (Million USD) by Players (2013-2018)

Table Global Neutropenia Treatment Revenue Share by Players (2013-2018)

Figure Global Neutropenia Treatment Revenue Share by Players in 2016

Figure Global Neutropenia Treatment Revenue Share by Players in 2017

Figure Global Top 5 Players Neutropenia Treatment Revenue Market Share in 2017

Figure Global Top 10 Players Neutropenia Treatment Revenue Market Share in 2017

Figure Global Neutropenia Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Neutropenia Treatment Revenue (Million USD) by Regions (2013-2018)

Table Global Neutropenia Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Neutropenia Treatment Revenue Market Share by Regions (2013-2018)

Figure Global Neutropenia Treatment Revenue Market Share by Regions in 2017

Figure North America Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Europe Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure South America Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Table North America Neutropenia Treatment Revenue by Countries (2013-2018)

Table North America Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure North America Neutropenia Treatment Revenue Market Share by Countries in 2017

Figure USA Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Canada Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Mexico Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Table Europe Neutropenia Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Europe Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure Europe Neutropenia Treatment Revenue Market Share by Countries in 2017

Figure Germany Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure UK Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure France Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Russia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Italy Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Neutropenia Treatment Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Neutropenia Treatment Revenue Market Share by Countries in 2017

Figure China Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Japan Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Korea Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure India Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Table South America Neutropenia Treatment Revenue by Countries (2013-2018)

Table South America Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure South America Neutropenia Treatment Revenue Market Share by Countries in 2017

Figure Brazil Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Argentina Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Colombia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Neutropenia Treatment Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Neutropenia Treatment Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Neutropenia Treatment Revenue Market Share by Countries in 2017

Figure Saudi Arabia Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure UAE Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Egypt Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure Nigeria Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Figure South Africa Neutropenia Treatment Revenue and Growth Rate (2013-2018)

Table Global Neutropenia Treatment Revenue (Million USD) by Type (2013-2018)

Table Global Neutropenia Treatment Revenue Share by Type (2013-2018)

Figure Global Neutropenia Treatment Revenue Share by Type (2013-2018)

Figure Global Neutropenia Treatment Revenue Share by Type in 2017

Table Global Neutropenia Treatment Revenue Forecast by Type (2018-2023)

Figure Global Neutropenia Treatment Market Share Forecast by Type (2018-2023)

Figure Global Granulocyte -colony- stimulating factor (G-CSF) Revenue Growth Rate (2013-2018)

Figure Global Antibiotics Revenue Growth Rate (2013-2018)

Figure Global Antifungal drugs Revenue Growth Rate (2013-2018)

Table Global Neutropenia Treatment Revenue by Application (2013-2018)

Table Global Neutropenia Treatment Revenue Share by Application (2013-2018)

Figure Global Neutropenia Treatment Revenue Share by Application (2013-2018)

Figure Global Neutropenia Treatment Revenue Share by Application in 2017

Table Global Neutropenia Treatment Revenue Forecast by Application (2018-2023)

Figure Global Neutropenia Treatment Market Share Forecast by Application (2018-2023)

Figure Global Hospital Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Online Pharmacy Revenue Growth Rate (2013-2018)

Figure Global Neutropenia Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Neutropenia Treatment Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Neutropenia Treatment Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Neutropenia Treatment Revenue Market Forecast (2018-2023)

Figure Europe Neutropenia Treatment Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Neutropenia Treatment Revenue Market Forecast (2018-2023)

Figure South America Neutropenia Treatment Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Neutropenia Treatment Revenue Market Forecast (2018-2023)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[好中球減少症治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (Global Neutropenia Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 / GIR8104458)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆